课题基金 / 基金详情

Peroxisome biogenesis and human peroxisome biogenesis disorders

Peroxisome biogenesis and human peroxisome biogenesis disorders
过氧化物酶体生物发生和人类过氧化物酶体生物发生障碍
批准号:
12308033
负责人:
FUJIKI Yukio
金额:
$31.9万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (A)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2002

项目摘要

项目成果

FUJIKI Yukio的其他基金

相似基金

相关文献

中文摘要
翻译
1)PEX 3编码42 kDa膜peroxin的克隆使用过氧化物酶体膜组装缺陷的CHO突变体,ZPG 208。PEX 3的功能障碍是导致过氧化物酶体生物合成障碍(PBD)如Zellweger综合征的原因。2)在3种RING过氧化物酶中,Pex 2 p、Pex 10 p和Pex 12 p RING指是过氧化物酶体恢复活性所必需的,但不是靶向过氧化物酶体所必需的。Pex 12 p RING finger结合Pex 10 p和过氧化物酶体靶向信号1(PTS 1)-受体Pex 5 p。3)我们表明,PEX 6(CG 4致病基因)恢复了CG 6 PBD成纤维细胞中的过氧化物酶体组装。该患者为PEX 6等位基因复合杂合子。因此,通过将CG 6与CG 4合并,将人PBD分为12个CG。4)Pex 5 p的两种同种型Pex 5 pS和37个氨基酸长的Pex 5 pL在哺乳动物中表达。我们发现Pex 5 pL与细胞质中的PTS 2受体Pex 7 p-PTS 2-蛋白复合物相互作用,并将它们易位到Pex 14 p。我们定义了函数 ...更多信息 nal Pex 5 p结构域与Pex 7 p、Pex 13 p和Pex 14 p相互作用。包含1-243位氨基酸残基的N-末端半Pex 5 pL与Pex 7 p、Pex 13 p和Pex 14 p结合,并且足以恢复pex 5细胞突变体的受损的PTS 2输入,而C-末端三肽重复基序是PTS 1结合所需的。Pex 5 p与Pex 14 p和Pex 13 p相互作用所必需的7个(Pex 5 pS中6个)五肽WxxxF/Y基序位于N-末端区域。Pex 14 p和Pex 13 p与负载PTS 1的Pex 5 p形成复合物,但在未负载货物的Pex 5 p存在下解离,因此意味着PTS货物在Pex 14 p下游和Pex 13 p上游的步骤从Pex 5 p释放。我们报道了Pex 7 p在CHO和人类细胞中在细胞质和过氧化物酶体之间显示双峰分布,这意味着Pex 7 p像Pex 5 p一样在过氧化物酶体和细胞溶质之间穿梭。Pex 7 p需要几乎全长,包括所有WD基序,用于其功能。5)我们最近使用CHO细胞突变体ZP 167分离了编码新的34-kDa II型过氧化物酶体膜蛋白的人PEX 26。PEX 26表达仅在CG 8 PBD患者的成纤维细胞中恢复过氧化物酶体蛋白输入。该患者具有一个纯合子,失活致病点突变,R98 W。因此,我们可以说,所有的致病基因负责12 CGs PBD已被克隆。此外,AAA ATP酶家族的Pex 6p和Pex 1 p与Pex 26 p共免疫沉淀。结合几条形态学证据,我们得出结论,Pex 26 p招募Pex 6p-Pex 1 p复合物过氧化物酶体。少
英文摘要
1) PEX3 encoding 42-kDa membrane peroxin was cloned by using a peroxisome membrane assembly-defective CHO mutant, ZPG208. Dysfunction of PEX3 was responsible for peroxisome biogenesis disorders (PBDs) such as Zellweger syndrome of complementation group G.2) Of 3 RING peroxins, including Pex2p, Pex10p, and Pex12p, Pex12p RING finger was essential for peroxisome restoring activity but not necessary for targeting to peroxisomes. Pex12p RING finger binds to Pex10p and peroxisome targeting signal 1 (PTS1)-receptor Pex5p.3) We showed that PEX6, the CG4 pathogenic gene, restored peroxisome assembly in CG6 PBD fibroblasts. This patient was compound heterozygous for PEX6 alleles. Accordingly, human PBDs are classified into 12 CGs by merging CG6 with CG4.4) Two isoforms of Pex5p, Pex5pS and 37-amino acid-longer Pex5pL, are expressed in mammals. We found that Pex5pL interacts with the PTS2 receptor Pex7p-PTS2-protein complexes in the cytosol and translocates them to Pex14p. We defined the functio … More nal Pex5p domains interacting with Pex7p, Pex13p, and Pex14p. An N-terminal half Pex5pL comprising amino acid residues at 1-243 bound to Pex7p, Pex13p and Pex14p and was sufficient for restoring the impaired PTS2 import of pex5 cell mutants, whilst the C-terminal tetratricopeptide repeat motifs were required for PTS1-binding. Seven (six in Pex5pS) pentapeptide WxxxF/Y-motifs residing at the N-terminal region were essential for Pex5p interaction with Pex14p and Pex13p. Pex14p and Pex13p formed a complex with PTS1-loaded Pex5p but dissociated in the presence of cargo-unloaded Pex5p, hence implying that PTS cargoes are released from Pex5p at the step downstream of Pex14p and upstream of Pex13p. We reported that Pex7p shows a bimodal distribution between the cytoplasm and peroxisomes in CHO and human cells, implying that Pex7p shuttles between peroxisomes and the cytosol, like Pex5p. Pex7p requires nearly the full length, including all WD motifs, for its function.5) We recently isolated human PEX26 encoding a novel, 34-kDa type II peroxisomal membrane protein, using a CHO cell mutant ZP167. PEX26 expression restored peroxisomal protein import in only the CG8 PBD patient's fibroblasts. This patient possessed a homozygous, inactivating pathogenic point mutation, R98W. Accordingly, we can state that all of pathogenic genes responsible for 12 CGs PBDs have been cloned. Moreover, Pex6p and Pex1p of the AAA ATPase family were co-immunoprecipitated with Pex26p. Together with several lines of morphological evidence, we concluded that Pex26p recruits Pex6p-Pex1p complexes to peroxisomes. Less
期刊论文(86)
专著(0)
科研奖励(0)
会议论文
Matsumoto, N.: "The novel pathogenic peroxin Pex26p recruits the Pex1p Pex6p AAA-ATPase complexes to peroxisomes"Nature Cell Biology. (in press). (2003)
Matsumoto, N.:“新型致病性过氧化物酶 Pex26p 将 Pex1p Pex6p AAA-ATP 酶复合物招募到过氧化物酶体”《自然细胞生物学》。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Matsumura, T.: "Disruption of interaction of the longer isoform of Pex5p, Pex5pL, with Pex7p abolishes the PTS2 protein import in mammals. Study with a novel PEX5-impaired Chinese hamster ovary cell mutant."J. Biol. Chem.. 275. 21715-21721 (2000)
Matsumura, T.:“破坏 Pex5p 较长亚型、Pex5pL 与 Pex7p 的相互作用会消除哺乳动物中的 PTS2 蛋白输入。用新型 PEX5 受损的中国仓鼠卵巢细胞突变体进行研究。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Ghaedi, K.: "PEX3 is the causal gene responsible for peroxisome membrane assembly-defective Zellweger syndrome of complementation group G."Am. J. Hum. Genet.. 67. 976-981 (2000)
Ghaedi, K.:“PEX3 是导致互补组 G 的过氧化物酶体膜组装缺陷 Zellweger 综合征的致病基因。”Am。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Mukai, S.: "Intracellular localization, function, and dysfunction of the peroxisome-targeting signal type 2 receptor, Pex7p, in mammalian cells."J. Biol. Chem.. 277. 9548-9561 (2002)
Mukai, S.:“哺乳动物细胞中过氧化物酶体靶向信号 2 型受体 Pex7p 的细胞内定位、功能和功能障碍。”J.
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 53 条
    Structure and Function of Peroxins Essential for Peroxisome Assembly
    • 批准号:
      20370039
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $12.98万
    • 财政年份:
      2008
    • 负责人:
      FUJIKI Yukio
    • 依托单位:
    Molecular Anatomy of Peroxisome Biogenesis and Human Disorders
    • 批准号:
      15207014
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $31.78万
    • 财政年份:
      2003
    • 负责人:
      FUJIKI Yukio
    • 依托单位:
    Peroxisome biogenesis and human peroxisome biogenesis disorders: Approaches to prenatal diagnosis and gene therapy
    • 批准号:
      12557017
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $8.38万
    • 财政年份:
      2000
    • 负责人:
      FUJIKI Yukio
    • 依托单位:
    Studies on Perxisome Biogenesis and Peroxisomal Disorders
    • 批准号:
      09044094
    • 项目类别:
      Grant-in-Aid for Scientific Research (B).
    • 资助金额:
      $5.95万
    • 财政年份:
      1997
    • 负责人:
      FUJIKI Yukio
    • 依托单位:
    海外基金